Ranitidine 150 MG Tablet

Ranitidine 150 MG Tablet is prescribed as the short-term treatment of active duodenal ulcers and benign gastric ulcers. This medicine is also prescribed for long-term prophylaxis of duodenal ulcer and gastric hypersecretory states, recurrent postoperative ulcer, prevention of acid-aspiration pneumonitis during surgery, and prevention of stress-induced ulcers; causes fewer interactions than cimetidine.

This medicine belongs to a drug group known as histamine (H2) receptor blocker. Ranitidine 150 MG Tablet works by reducing the amount of acid produced in the stomach, effectively treating gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome and upper GI bleeding ulcers.

Patients need to be aware that intake of this medicine can increase the chances of succumbing to pneumonia. Its symptoms are pain in the chest, fever, coughing up slimy green snot and problems with breathing. Also, make sure that you are not allergic to this medication.

Make sure it is safe for you to consume this medication if you suffer from health problems like liver, kidney disease and porphyria. Although this medication does not really harm an unborn child, ensure that you tell your doctor if you are pregnant.

This medicine does pass into breast build, thus let your doctor know if you are taking this medication while breastfeeding too. It should be taken according to instructions given by the doctor. Do not change the dosage on your own.

This medication is meant for oral consumption and should be swallowed immediately. Do not chew or let the effervescent tablet dissolve after you place it in your mouth.

For instance, if you are taking 25 mg of it, dissolve it in 1 teaspoon of water. If you are taking 150 mg of this medicine, it should be dissolved in 6-8oz of water. It should be continued until the ulcer heals completely. Generally, it takes about 8 weeks for an ulcer to properly heal.

Take exactly as directed (at meals and bedtime); do not increase dose - may take several days before you notice relief. If antacids are approved by prescriber, allow 1 hour between antacid and Ranitidine 150 MG Tablet.

Avoid OTC medications, especially cold or cough medication and aspirin or anything containing aspirin. Follow the diet as the prescriber recommends.

Symptoms of overdose include muscular tremors, vomiting, rapid respiration, renal failure, CNS depression. Treatment is primarily symptomatic and supportive.

Use with caution in children <12 years of age; use with caution in patients with liver and renal impairment; dosage modification required in patients with renal impairment; long-term therapy may cause vitamin B12 deficiency.

This medication is helpful in treating the below provided problems

• Duodenal Ulcer

• Gastric Ulcer

• Gastroesophageal Reflux Disease

• Erosive Esophagitis

• Zollinger-Ellison Syndrome

• Hypersecretory Condition

• Other Forms Of Ulcers

• Hypersensitivity

  This medication is not recommended for use in patients who have a known history of allergy to Ranitidine (the primary constituent of Ranitidine) or any other component of the medicine.

Common side effects of this medication are as follows

• Headache

• Dizziness

• Nausea Or Vomiting

• Diarrhoea

• Mental Confusion

• Difficulty In Breathing

• Gynecomastia

• Rash

• Sedation

• Arthralgia

• Fever

• How long is the duration of effect?

  The effect of this medication lasts for an average duration of 6 - 8 hours.

• What is the onset of action?

  The effect of this medication can be observed after an hour of oral administration.

• Are there any pregnancy warnings?

  Caution is advised while using this medicine during pregnancy. You should consult a doctor and use this medication only if the benefits outweigh the risks associated.

• Is it habit forming?

  No habit forming tendencies were reported.

• Are there any breast-feeding warnings?

  Caution is advised while using this medicine during pregnancy. You should consult a doctor and use this medication only if the benefits outweigh the risks associated.

• Does this affect kidney function?

  Dose adjustment is advised in the patient with renal impairment.

• Does this affect liver function?

  No information regarding dose adjustment is available in hepatic patients.

• Is It safe with alcohol?

  It is suggested not to take Ranitidine 150 MG Tablet with alcohol, as it is unsafe to take it concomitantly.

• Is it safe to drive while on this medicine?

  Driving is usually safe if you are taking Ranitidine 150 MG Tablet. As this medicine does not affect patients ability to drive.

Below is the list of medicines, which have the same composition, strength and form as Ranitidine 150 MG Tablet , and hence can be used as its substitute.

• Antec 150 MG Tablet

  Abbott Healthcare Pvt. Ltd

• Helkoss 150 MG Tablet

  Lupin Ltd

• Zytak 150 MG Tablet

  Zydus Cadila

• Renitab 150 MG Tablet

  Micro Labs Ltd

• Alep 0.25 MG Tablet

  Dr. Johns Laboratories Pvt Ltd

• Are there any missed dose instructions?

  Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, then the missed dose can be skipped.

• Are there any overdose instructions?

  Contact a doctor immediately if an overdose is suspected.

This medication acts by inhibiting the action of histamine at specific H2 receptors present in the gastric parietal cells. Thus, gastric acid secretion process is inhibited. Thus, gastric volume and hydrogen ion concentration reduced.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

• Interaction with Alcohol

  Avoid the consumption of alcohol while taking this medicine. Contact your doctor if you experience prolonged heartburn or presence of blood in the vomit or stools.

• Interaction with Lab Test

  False-positive urine protein, gastric acid secretion test, skin test allergen extracts, serum creatinine and serum transaminase concentrations, urine protein test might appear. Thus before testing must inform your doctor that you are taking Ranitidine 150 MG Tablet

• Interaction with Medicine

  • Ketoconazole: Report the use of either of the medicine to the doctor. The use of this medication tends to make Ketoconazole less effective. Inform the doctor if the symptoms do not improve or worsen. Do not discontinue the use of any medicine without consulting your doctor.
  • Loperamide: Report the use of either of the medicine to the doctor. Dose adjustment and safety monitoring may be needed when both these medicines are taken together. Your doctor may prescribe alternative medicine if your intake of Loperamide is very high or you suffer have a heart condition.
  • Metformin: Report the use of either of the medicine to the doctor. An adjustment in dose and more frequent monitoring of blood level are advised when these two medicines are taken together.
  • Atazanavir: Report the use of either of the medicine to the doctor. Your doctor may adjust the dosage of Atazanavir when it is to be consumed along with this medication. Do not stop the usage of any medication without consulting your doctor.
  • Dasatinib: Report the usage of either of the medications to the doctor. It is advised to replace one or both of these medicines with alternates that do not interact. Do not stop the usage of any medication without consulting the doctor.
  • Pazopanib: Report the use of either of the medicine to the doctor. Use of these two medications together should be avoided. Your doctor may prescribe suitable alternatives in such cases.
  • Decreased toxicity of atropine.
  • Increased toxicity of cyclosporine (increased serum creatinine), gentamicin (neuromuscular blockade), glipizide, glyburide, midazolam (increased concentrations), metoprolol, pentoxifylline, phenytoin, quinidine.

• Interaction with Disease

  • Gastrointestinal Bleeding: Use of this medication is not recommended for use if any symptoms indicating gastrointestinal bleeding exists. Consult your doctor if there is blood in vomit or the stools are bloody or black.
  • Porphyria: This medication should be used with extreme caution in patients having a history of acute Porphyria.